Hypersensitivity  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
aHUS, NCT00844428 / 2008-006955-28: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive

Completed
2
5
Canada, Europe
eculizumab
Alexion Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
10/10
12/13
aHUS, NCT00838513 / 2008-006954-17: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome

Completed
2
15
Canada, Europe
eculizumab
Alexion Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
10/10
12/13

Download Options